Available Careers
Cambrian Bio Presents Positive Human Translational Data for ATX-304, the First AMPK Network Activator, at the American Diabetes Association's 86th Scientific Sessions
10 mins to read
18
June
26
Cambrian Bio Presents Positive Human Translational Data for ATX-304, the First AMPK Network Activator, at the American Diabetes Association's 86th Scientific Sessions
18
June
26
10 mins to read
min read
Cambrian Bio to Present Two Posters on ATX-304 at the American Diabetes Association 86th Scientific Sessions
5 mins to read
3
June
26
Cambrian Bio to Present Two Posters on ATX-304 at the American Diabetes Association 86th Scientific Sessions
3
June
26
5 mins to read
min read
Cambrian Bio Awarded Up to $30.8 Million as part of ARPA-H's PROSPR Program to Advance a Novel mTORC1-Selective Inhibitor for Improving Intrinsic Capacity in Older People
5 mins to read
24
February
26
Cambrian Bio Awarded Up to $30.8 Million as part of ARPA-H's PROSPR Program to Advance a Novel mTORC1-Selective Inhibitor for Improving Intrinsic Capacity in Older People
24
February
26
5 mins to read
min read
